Iranian Journal of Radiology

Published by: Kowsar

Assessment of Lipiodol Deposition and Residual Cancer for Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization via Iodine-Based Material Decomposition Images with Spectral Computed Tomography Imaging: A Preliminary Study

Yanhong Xu 1 , An Xiao 2 , Jia Yang 1 , Zaixian Zhang 1 and Guixiang Zhang 1 , *
Authors Information
1 Department of Radiology, Shanghai First People’s Hospital, School of Medicine, Jiao Tong University, Shanghai, China
2 Department of Interventional Radiology, Shanghai First People’s Hospital, School of Medicine, Jiao Tong University, Shanghai, China
Article information
  • Iranian Journal of Radiology: October 01, 2015, 12 (4); e26009
  • Published Online: August 5, 2015
  • Article Type: Research Article
  • Received: December 10, 2014
  • Revised: January 13, 2015
  • Accepted: February 14, 2015
  • DOI: 10.5812/iranjradiol.26009

To Cite: Xu Y, Xiao A, Yang J, Zhang Z, Zhang G. Assessment of Lipiodol Deposition and Residual Cancer for Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization via Iodine-Based Material Decomposition Images with Spectral Computed Tomography Imaging: A Preliminary Study, Iran J Radiol. 2015 ; 12(4):e26009. doi: 10.5812/iranjradiol.26009.

Abstract
Copyright © 2015, Tehran University of Medical Sciences and Iranian Society of Radiology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011; 365(12): 1118-27[DOI][PubMed]
  • 2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61(2): 69-90[DOI][PubMed]
  • 3. Maluccio M, Covey A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012; 62(6): 394-9[DOI][PubMed]
  • 4. Miao R, Luo H, Zhou H, Li G, Bu D, Yang X, et al. Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis. J Hepatol. 2014; 61(4): 840-9[DOI][PubMed]
  • 5. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009; 27(9): 1485-91[DOI][PubMed]
  • 6. Kim do Y, Han KH. Epidemiology and surveillance of hepatocellular carcinoma. Liver Cancer. 2012; 1(1): 2-14[DOI][PubMed]
  • 7. Yeganeh B, Hashemi M, de Serres FJ, Los MJ, Ghavami S. Different faces of hepatocellular carcinoma as a health threat in 21st century. Hepat Mon. 2013; 13(2)[DOI][PubMed]
  • 8. Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis. 2010; 30(1): 3-16[DOI][PubMed]
  • 9. Mazioti A, Gatselis NK, Rountas C, Zachou K, Filippiadis DK, Tepetes K, et al. Safety and efficacy of transcatheter arterial chemoemboliazation in the real-life management of unresectable hepatocellular carcinoma. Hepat Mon. 2013; 13(8)[DOI][PubMed]
  • 10. Ghanaati H, Alavian SM, Jafarian A, Ebrahimi Daryani N, Nassiri-Toosi M, Jalali AH, et al. Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of Evidence. Iran J Radiol. 2012; 9(4): 167-77[DOI][PubMed]
  • 11. Kubota K, Hisa N, Nishikawa T, Fujiwara Y, Murata Y, Itoh S, et al. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of Lipiodol-CT, power Doppler sonography, and dynamic MRI. Abdom Imaging. 2001; 26(2): 184-90[PubMed]
  • 12. Chen CY, Li CW, Kuo YT, Jaw TS, Wu DK, Jao JC, et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants--initial experience. Radiology. 2006; 239(2): 448-56[DOI][PubMed]
  • 13. Kubota K, Yamanishi T, Itoh S, Murata Y, Miyatake K, Yasunami H, et al. Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinoma. Oncol Rep. 2010; 24(3): 727-32[PubMed]
  • 14. Huppertz A, Balzer T, Blakeborough A, Breuer J, Giovagnoni A, Heinz-Peer G, et al. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology. 2004; 230(1): 266-75[DOI][PubMed]
  • 15. Wang Z, Lin M, Lesage D, Chen R, Chapiro J, Gu T, et al. Three-dimensional evaluation of lipiodol retention in HCC after chemoembolization: a quantitative comparison between CBCT and MDCT. Acad Radiol. 2014; 21(3): 393-9[DOI][PubMed]
  • 16. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012; 379(9822): 1245-55[DOI][PubMed]
  • 17. Marin-Hargreaves G, Azoulay D, Bismuth H. Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol. 2003; 47(1): 13-27[PubMed]
  • 18. Monsky WL, Kim I, Loh S, Li CS, Greasby TA, Deutsch LS, et al. Semiautomated segmentation for volumetric analysis of intratumoral ethiodol uptake and subsequent tumor necrosis after chemoembolization. AJR Am J Roentgenol. 2010; 195(5): 1220-30[DOI][PubMed]
  • 19. Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, et al. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol. 2001; 176(3): 681-8[DOI][PubMed]
  • 20. Lee HS, Kim KM, Yoon JH, Lee TR, Suh KS, Lee KU, et al. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. J Clin Oncol. 2002; 20(22): 4459-65[PubMed]
  • 21. Takayasu K, Arii S, Matsuo N, Yoshikawa M, Ryu M, Takasaki K, et al. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol. 2000; 175(3): 699-704[DOI][PubMed]
  • 22. Lin XZ, Wu ZY, Tao R, Guo Y, Li JY, Zhang J, et al. Dual energy spectral CT imaging of insulinoma-Value in preoperative diagnosis compared with conventional multi-detector CT. Eur J Radiol. 2012; 81(10): 2487-94[DOI][PubMed]
  • 23. Lv P, Lin XZ, Li J, Li W, Chen K. Differentiation of small hepatic hemangioma from small hepatocellular carcinoma: recently introduced spectral CT method. Radiology. 2011; 259(3): 720-9[DOI][PubMed]
  • 24. Zhang XF, Lu Q, Wu LM, Zou AH, Hua XL, Xu JR. Quantitative iodine-based material decomposition images with spectral CT imaging for differentiating prostatic carcinoma from benign prostatic hyperplasia. Acad Radiol. 2013; 20(8): 947-56[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments